Inovio Pharmaceuticals
INO
INO
78 hedge funds and large institutions have $116M invested in Inovio Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
28% more call options, than puts
Call options by funds: $660K | Put options by funds: $516K
0.13% more ownership
Funds ownership: 0.17% → 0.3% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
78
Holding in Top 10
1
Calls
$660K
Puts
$516K
Top Buyers
| 1 | +$15.5M | |
| 2 | +$13.3M | |
| 3 | +$9.21M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.5M |
| 5 |
Jennison Associates
New York
|
+$4.16M |
Top Sellers
| 1 | -$7.88M | |
| 2 | -$2.79M | |
| 3 | -$725K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$191K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$121K |